Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
oral drug delivery platform
Biotech
Merck's oral COVID-19 antiviral slashes hospitalizations
The prospect halved the risk of hospitalization and death in phase 3, spurring Merck to stop the study and race to get emergency use authorization.
Nick Paul Taylor
Oct 1, 2021 6:47am
Tvardi stacks the bank with $74M series B for STAT3 inhibitor
Jun 23, 2021 8:00am
KalVista's rival to Firazyr aces trial, sending stock up 200%
Feb 9, 2021 8:25am
Harvard spins out oral biologic tech with a focus on diabetes
Apr 9, 2020 3:05pm
Rani completes first human study of its robotic biologic pill
Mar 1, 2019 2:24pm
An oral insulin delivery system inspired by tortoises
Feb 7, 2019 2:00pm
